Spinal Injectable Market on a Remarkable Ascent: Expected to Reach US$ 51.2 Billion by 2033
In 2023, the Spinal Injectable Market is expected to be worth US$23.3 billion. The market is expected to exceed US$ 51.2 billion by 2033, growing at an 8.2% CAGR during the forecast period. Because of the exponentially increasing prevalence of chronic lower back pain, the global market for spinal injectables is expe...
Source: pharmiweb.com